Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2016

View Archived Issues

Antimitotic compound leiodermatolide reduces pancreatic tumor weights in vivo

IdeS reduces HLA antibodies in kidney transplant candidates

Novel compound E-6887 shows promise for treating lupus

U.S. HHS awards contracts to support development of Zika virus diagnostic tests

Hemispherx Biopharma's NDA for rintatolimod receives approval in Argentina

Orally available peptides from Protagonist Therapeutics show promise for treating IBD

Biotron identifies new compounds in Zika program, signs agreement with NIAID

EMA validates Cempra's MAA for solithromycin

Oncology Venture updates progress of phase I trial of LiPlaCis

Innovative Targeting Solutions signs agreement with Janssen Biotech

FORMA Therapeutics describes HDAC inhibitors

Immune Therapeutics initiates Malawi study of LDN for prevention of cervical cancer

FDA grants breakthrough status to Stemline's SL-401

Cyon Therapeutics licenses Novartis' anti-PCSK9 antibody LGT-209

Temple University discovers novel 5-HT7 antagonists to treat inflammatory bowel disease

Pfizer to acquire AstraZeneca's small molecule anti-infectives business

FDA accepts Clovis' NDA for rucaparib

GlaxoSmithKline and Astex present a novel potent and reversible inhibitor of PAF acetylhydrolase

Biocardia merges with Tiger X Medical, forms new entity

AiCuris Anti-infective Cures' pritelivir achieves primary endpoint in phase I trial

Nanoantibiotics changes name to Biovie

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...